CD8A (Crefmirlimab) Recombinant Monoclonal Antibody
Regular price
$575.00 USD
Sale price
Regular price
Unit price
/per
Shipping calculated at checkout.
Available in stock (500)
Request a Quote
✅ Thank you! Your quote request was sent successfully.
❌ Something went wrong. Please check your details and try again.
- Customs clearance fees may apply
- Worldwide shipping available.
Couldn't load pickup availability
For research use only — not intended for clinical or diagnostic purposes.
Product Overview
Product Overview
Accession number
P01732
Applications
ELISA
Buffer
{"type":"root","children":[{"type":"paragraph","children":[{"type":"text","value":"0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4"}]}]}
Clonality
Recombinant Monoclonal
Clone number
9F1
Concentration
Lot specific. Please inquire or refer to the datasheet included in the product pouch.
Conjugate
Unconjugated. Conjugated antibodies are available (Biotin, FITC and HRP), please inquire.
Description
The CD8A (Crefmirlimab) Recombinant Monoclonal Antibody is applicable for the following applications: ELISA
Expiration
12 months
Format
Liquid
Host
Human
Immunogen
Recombinant Human CD8A protein
Isotype
IgG2
Lead time for package collection
7-11 Business Days
Purification
Affinity chromatography
Quality systems
This product is manufactured at ISO 9001 certified facilities.
Research area
Others
Restrictions
For Research Use Only. Not for use in diagnostic procedures.
Shipping conditions
Ice packs
Species
Human (Homo sapiens)
Species reactivity
Human (Homo sapiens)
Storage
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Target name
CD8A
Target synonyms
alpha polypeptide (p32); CD8; CD8 antigen alpha polypeptide; CD8 antigen alpha polypeptide (p32); CD8a; CD8A antigen; CD8A molecule; CD8A_HUMAN; Leu2; Leu2 T lymphocyte antigen; Ly3; LYT3; MAL; OKT8 T cell antigen; OTTHUMP00000160760; OTTHUMP00000160764; OTTHUMP00000203528; OTTHUMP00000203721; p32; T cell antigen Leu2; T cell co receptor; T-cell surface glycoprotein CD8 alpha chain; T-lymphocyte differentiation antigen T8/Leu-2; T8 T cell antigen; T8/Leu-2 T-lymphocyte differentiation antigen
Background
Background
The CD8A (Crefmirlimab) Recombinant Monoclonal Antibody is applicable for the following applications: ELISA. Host: Human. Species Reactivity: Human (Homo sapiens). Immunogen: Recombinant Human CD8A protein. Accession Number: P01732. Target Synonyms: alpha polypeptide (p32); CD8; CD8 antigen alpha polypeptide; CD8 antigen alpha polypeptide (p32); CD8a; CD8A antigen; CD8A molecule; CD8A_HUMAN; Leu2; Leu2 T lymphocyte antigen; Ly3; LYT3; MAL; OKT8 T cell antigen; OTTHUMP00000160760; OTTHUMP00000160764; OTTHUMP00000203528; OTTHUMP00000203721; p32; T cell antigen Leu2; T cell co receptor; T-cell surface glycoprotein CD8 alpha chain; T-lymphocyte differentiation antigen T8/Leu-2; T8 T cell antigen; T8/Leu-2 T-lymphocyte differentiation antigen. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Documents
Documents
Product Citations
Product Citations
More Info
More Info
CD8A (Crefmirlimab) Recombinant Monoclonal Antibody
Regular price
$575.00 USD
Sale price
Regular price
Unit price
/per

